Literature DB >> 24813169

"To combine or not to combine": optimizing risk assessment before allogeneic hematopoietic cell transplantation.

Mahmoud ElSawy1, Barry E Storer2, Mohamed L Sorror3.   

Abstract

Mesh:

Year:  2014        PMID: 24813169     DOI: 10.1016/j.bbmt.2014.05.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  5 in total

1.  Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.

Authors:  Brandon K C Au; Ted A Gooley; Philippe Armand; Min Fang; David K Madtes; Mohamed L Sorror; Michael J Boeckh; Christopher J Gibson; Hans Joachim Deeg; Rainer Storb; Frederick R Appelbaum; Jason W Chien; Paul J Martin
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-31       Impact factor: 5.742

Review 2.  Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.

Authors:  M Elsawy; M L Sorror
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

3.  Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation.

Authors:  P Barba; R Martino; G Orti; A Esquirol; S Perez-Hoyos; J Sierra; D Valcárcel
Journal:  Bone Marrow Transplant       Date:  2015-06-22       Impact factor: 5.483

4.  Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Authors:  Thomas A Fox; Ronjon Chakraverty; Siobhan Burns; Benjamin Carpenter; Kirsty Thomson; David Lowe; Adele Fielding; Karl Peggs; Panagiotis Kottaridis; Benjamin Uttenthal; Venetia Bigley; Matthew Buckland; Victoria Grandage; Shari Denovan; Sarah Grace; Julia Dahlstrom; Sarita Workman; Andrew Symes; Stephen Mackinnon; Rachael Hough; Emma Morris
Journal:  Blood       Date:  2017-12-26       Impact factor: 25.476

Review 5.  Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.

Authors:  Servais Sophie; Beguin Yves; Baron Frédéric
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.